ENZYMATIC METHOD FOR PREPARATION OF GDP-FUCOSE
20240124911 ยท 2024-04-18
Inventors
Cpc classification
C12P19/18
CHEMISTRY; METALLURGY
C12P19/00
CHEMISTRY; METALLURGY
C12Y402/01047
CHEMISTRY; METALLURGY
C12Y207/07022
CHEMISTRY; METALLURGY
C12Y207/07013
CHEMISTRY; METALLURGY
C12Y207/0703
CHEMISTRY; METALLURGY
C12P19/32
CHEMISTRY; METALLURGY
C12P19/44
CHEMISTRY; METALLURGY
International classification
Abstract
The present invention relates to an enzyme-catalyzed process for producing GDP-fucose from low-cost substrates guanosine and
Claims
1.-19. (canceled)
20. A method for producing guanosine 5-diphospho-?-
21. The method according to claim 20, wherein the set of enzymes further comprises a pyrophosphatase.
22. The method according to claim 20, wherein the set of enzymes is co-immobilized on a solid support.
23. The method according to claim 22, wherein the set of enzymes is immobilized on a solid support from cell lysate or the set of enzymes is co-immobilized on a solid support from cell lysate.
24. The method according to claim 20, wherein the concentration of guanosine and
25. The method according to claim 20, wherein the polyphosphate is a long-chain polyphosphate having at least 25 phosphate residues.
26. The method according to claim 20, wherein the guanosine 5-diphospho-?-
27. The method according to claim 20, wherein the amount of co-solvent is from 0.01 vol % to 30 vol % based on total volume of the solution provided in step A).
28. The method according to claim 20, wherein the co-solvent is dimethyl sulfoxide.
29. The method according to claim 20, wherein the method further comprises the step producing
30. The method according to claim 20, further comprising the step of isolating the guanosine 5-diphospho-?-
31. The method according to claim 20, further comprising the step of producing a fucosylated saccharide, fucosylated glycopeptide, fucosylated glycoprotein fucosylated protein, fucosylated peptide or small molecule from guanosine 5-diphospho-?-
32. The method according to claim 20, wherein the set of enzymes further comprises any one of a glucose dehydrogenase, a glucose-6-phosphate dehydrogenase and a glutamate dehydrogenase.
33. The method according to claim 32, wherein the set of enzymes further comprises a guanylate kinase.
34. The method according to claim 20, wherein the guanosine kinase comprises an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 8; the polyphosphate kinase comprises an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 9 or SEQ ID NO. 14; the mannose-1-phosphate guanylyltransferase comprises an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 1, the GDP-mannose-4,6-dehydratase comprises an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 5, the GDP-L-fucose-synthase comprises an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 6, the glucokinase comprises an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 1, the phosphomannomutase comprises an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 2, and the N-acetylhexosamine-1-kinase comprises an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 3.
35. The method according to claim 34, wherein the guanosine kinase comprises an amino acid sequence of SEQ ID NO: 8; the polyphosphate kinase comprises an amino acid sequence of SEQ ID NO: 9 or SEQ ID NO. 14; the mannose-1-phosphate guanylyltransferase comprises an amino acid sequence of SEQ ID NO: 1, the GDP-mannose-4,6-dehydratase comprises an amino acid sequence of SEQ ID NO: 5, the GDP-L-fucose-synthase comprises an amino acid sequence of SEQ ID NO: 6, the glucokinase comprises an amino acid sequence of SEQ ID NO: 1, the phosphomannomutase comprises an amino acid sequence of SEQ ID NO: 2, and the N-acetylhexosamine-1-kinase comprises an amino acid sequence of SEQ ID NO: 3.
Description
DESCRIPTION OF THE FIGURES
[1240]
[1241]
[1242]
[1243]
[1244]
[1245]
[1246]
[1247]
[1248]
[1249]
[1250]
[1251]
[1252]
[1253]
[1254]
[1255]
[1256]
[1257]
[1258]
[1259]
[1260]
[1261]
[1262] The following examples are included to demonstrate preferred embodiments of the invention. It should be appreciated by those skilled in the art that the techniques disclosed in the examples, which follow represent techniques discovered by the inventor to function well in the practice of the invention, and thus can be considered to constitute preferred modes for its practice. However, those skilled in the art should, in light of the present disclosure, appreciate that many changes can be made in the specific embodiments, which are disclosed and still obtain a like or similar result without departing from the spirit and scope of the invention.
[1263] Further modifications and alternative embodiments of various aspects of the invention will be apparent to those skilled in the art in view of this description. Accordingly, this description is to be construed as illustrative only and is for the purpose of teaching those skilled in the art the general manner of carrying out the invention. It is to be understood that the forms of the invention shown and described herein are to be taken as examples of embodiments. Elements and materials may be substituted for those illustrated and described herein, parts and processes may be reversed, and certain features of the invention may be utilized independently, all as would be apparent to one skilled in the art after having the benefit of this description of the invention. Changes may be made in the elements described herein without departing from the spirit and scope of the invention as described in the following claims.
EXAMPLES
Abbreviations and Acronyms
[1264] ADP adenosine 5-diphosphate [1265] ATP adenosine 5-triphosphate [1266] Fuc
[1295] Chemicals & Reagents
[1296] Unless otherwise stated, all chemicals and reagents were acquired from Sigma-Aldrich, and were of the highest purity available. Solid supports were obtained from Resindion, ChiralVision, R?hm GmbH & Co. KG and micromod GmbH.
Example 1: Preparation of Enzymes
[1297] The genes encoding for the enzymes GSK, PPK2, FKP and PmPpA were cloned into standard expression vectors as listed in Table 1. The expression vectors were transformed into E. coli BL21 Gold (DE3).
TABLE-US-00001 TABLE 1 Expression Enzyme Source Plasmid Inducer host guanosine kinase Exiguobacterium pET-28a(+) IPTG E. coli BL21 (GSK) acetylicum Gold (DE3) polyphosphate kinase Pseudomonas pET-28a(+) IPTG E. coli BL21 (2D-PPK2) aeruginosa Gold (DE3) L-fucokinase/L-fucose-1- Bacteroides pET-100/D- IPTG E. coli BL21 phosphate- fragilis TOPO Gold (DE3) guanylyltransferase (FKP) inorganic pyrophosphatase Pasteurella pET-28a(+) IPTG E. coli BL21 (PmPpA) multocida Gold (DE3)
[1298] Transformants were grown in 1 L shaking flasks with baffles in a volume of 500 ml of LB medium (lysogeny broth) supplemented with 50 ?g/ml Kanamycin. The cultures were grown at 37? C. up to OD.sub.600=0.8. The expression was induced by addition of IPTG with a final concentration of 0.5 mM to the culture. Expression time was terminated after 12-18 hours at 20? C. Biomass was separated from the medium by centrifugation at 6,000?g for 10 min. Successful expression of the respective enzyme was analyzed by SDS-PAGE following standard operating procedures (Laemmli, Nature 1970, 227, 680-685). The wet biomass was stored at ?20? C.
[1299] For purification, typically 30 ml of equilibration buffer were added to 3 g of frozen biomass. The equilibration buffer contains cOmplete? protease inhibitor cocktail at pH 7.5: 100 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 10 mM MgCl.sub.2, 5 mM MnSO.sub.4, 300 mM NaCl and 5 vol % glycerol. Following thawing at 4? C. under stirring, cells were disrupted by four passages through a high pressure homogenizer (Emulsiflex C5, Avestin Inc., Ottawa, Canada) at 1,000 bar with intermediate cooling on ice. After centrifugation (45 min, 20,000?g), the supernatant was applied to an equilibrated Immobilized Metal Affinity Chromatography (IMAC) column (10 ml CV) containing Ni.sup.2+ Sepharose? High Performance chromatography material from Amersham Biosciences (Uppsala, Sweden). Unbound proteins were washed out using equilibration buffer. Immobilized protein was eluted in 1 ml fractions using elution buffer. Finally, the enzyme solutions were concentrated by Centrifugal Filter Units Amicon? Ultra-15 with a 50 kDa cut-off from Merck Millipore (Darmstadt, Germany). No enzyme loss was observed during the ultrafiltration. The enzymes were stored in 50% glycerol at ?20? C. The protein concentration was determined by Bradford assay using BSA as standard (Bradford, Analytical Biochemistry 1976, 72(1), 248-254).
Example 2: Homogeneous Preparation of GDP-Fucose
[1300] The purified enzymes (Table 1) are mixed together with guanosine,
TABLE-US-00002 TABLE 2 Reactants Concentration [mmol/L] guanosine 2 polyphosphate (n = 14 or 25) 4 L-fucose 2 ATP 2 HEPES Buffer 50 Ma.sup.2+ 2.5 Mn.sup.2+ 2.5 Enzyme Concentration [mg/mL] GSK 0.3 2D-PPK2 0.7 FKP 0.2 PmPpA 0.2
[1301] After almost three hours 90% conversion of substrate (guanosine) to GDP-fucose was obtained (See
Example 3: Failed Synthesis of GDP-Fucose
[1302] The synthesis of GDP-fucose was carried out as described in Example 2, but without adding DMSO. The reaction was carried out at 30? C. in a thermomixer and the obtained reaction mixture remained turbid. After three hours no conversion of substrate (guanosine) to GDP-fucose was observed.
[1303] This Example demonstrates that the mere combination of the two enzymatic pathways does not provide GDP-fucose.
Example 4: Immobilization of Enzymes on Solid Support
[1304] Enzymes were immobilized on the solid supports in order to allow the multiple use of the enzymes.
[1305] Cell lysates obtained in Example 1 by high pressure homogenization were centrifuged and filtered to remove cell debris. The resins: sepabeads (Resindion): EC-EP, EP403/M, EC-HFA, EC-EA/M and EC-HA; immobeads (ChiralVision) IB-COV1, IB-COV2, IB-COV3, IB-AN11, IB-AN12, IB-AN13, IB-AN14, IB-CAT1, IB-ADS1, IB-ADS2, IB-ADS3 and IB-ADS4; Eupergit (R?hm GmbH & Co. KG) and magnetic particles (micromod GmbH): Nano-mag, Sicastar-6 and Sicastar-1.5 wer incubated together with the enzymes for 24 hours at 4? C.
[1306] The protein assay was done by BCA assay. Results of total bound protein are shown in
[1307] After immobilization the enzyme loaded resins were washed with buffer as described in Example 1. The resins were incubated with a solution of reactants as shown in Table 3 at 30? C. for 24 hours.
TABLE-US-00003 TABLE 3 Reactants Concentration [mmol/L] guanosine 3.9 (4 vol % DMSO) polyphosphate (n = 25) 12.5 L-fucose 5.3 ATP 12 HEPES Buffer 120 MgCl.sub.2 8 MnCl.sub.2 8 NaCl 200
[1308] The formation of GDP-fucose was observed for all loaded resins, as shown in
Example 5: Heterogeneous Preparation of GDP-Fucose on Magnetic Particles
[1309] To this extent, fermentation broths (see Example 1) of 135 mL of FKP, 45 mL of PmPpA, 90 mL GSK and 90 mL of 2D-PPK2 were combined and lysed in 25 mL buffer (as described in Example 1) containing 10 mM imidazole, to obtain 0.5 mL of an enzyme mixture, which was incubated with 12.5 mg of Sicastar-6 magnetic resins. After 1 hour of incubation at 10? C., resins were washed with buffer and combined in a vial with 0.25 mL of a solution of reagents (see Table 4). The mixture was incubated at 30? C. for 48 hours.
TABLE-US-00004 TABLE 4 Reactants Concentration [mmol/L] guanosine 6 (4 vol % DMSO) polyphosphate (n = 25) 9.3 L-fucose 6 ATP 9.6 HEPES Buffer 50 MgCl.sub.2 15 MnCl.sub.2 5 NaCl 30 KCl 30
[1310] After 48 hours nearly quantitative conversion (98%) of substrate (guanosine) to GDP-fucose was obtained (See
Example 6: Recycling of NADPH
[1311] A one-pot reaction was conducted (see reaction conditions of reaction A1 in Table 5) to show that the equilibrium of the GDP-mannose 4,6-dehydratase (GMD, E.C. 4.2.1.47) and GDP-L-fucose synthase (wcaG, E.C. 1.1.1.271) catalyzed reactions from GDP-mannose to GDP-fucose is on the side of GDP-mannose (see
[1312] To push the equilibrium of the reaction towards GDP-Fuc, coupling to another reaction (in a way that NADP.sup.+ is constantly removed) needs to be engineered. In reaction A2 the enzymes Glk, PPK3 and glucose-6-phosphate-dehydrogensase (purchased from Merck10165875001) (G6PDH, E.C: 1.1.1.49) were used to recycle NAPDH and increase the GDP-fucose yield. In this experiment, first the enzymes were dispensed into a vial up to the amounts mentioned in the table 6. After addition of enzymes, buffer, co-factor, GDP-Man, NADPH, glucose, ATP and polyphosphate were added in this order, up to the mentioned concentrations in table 6. The reaction was performed in a 1.5 mL Eppendorf vial, at 37? C. and 550 rpm in the Eppendorf thermomixer Comfort. Aliquots were taken at different time points and quenched by heating at 90? C. for 3 minutes and then measured by ion exchange chromatography. For the recycling the inexpensive substrates glucose and polyphosphate are used as substrates (see
[1313] Another experiment was performed for the production of GDP-Fuc from Man, ATP, GTP and polyphosphate, and L-glutamate for the regeneration of NADPH and shifting the equilibrium towards GDP-Fuc. In this experiment, first enzymes were dispensed into a vial up to the amounts mentioned in the table 7. After addition of enzymes, buffer, co-factor, Man, GTP, ATP and L-glutamate, and polyphosphate were added in this order, up to the mentioned concentrations in table 7. The reaction was performed in a 1.5 mL Eppendorf vial, at 37? C. and 550 rpm in the Eppendorf thermomixer Comfort. Aliquots were taken at different time points and quenched by heating at 90? C. for 3 minutes and then measured by ion exchange chromatography. In reaction A3 (see reaction conditions of reaction A3 in Table 7) glutamate dehydrogenase (purchased from Merck10197734001) (GLDH, E.C. 1.4.1.4) was used to recycle NADPH from L-glutamate and water. (see
TABLE-US-00005 TABLE 5 Reactions conditions of examples A1. Enzymes Concentration WCAG 1.03 ?g/?L GMD 1.75 ?g/?L Substrates GDP-Man 2 mM NADPH 2 mM Buffer and co-factor Tris-HCl (pH = 8) 100 mM MgCl.sub.2 10 mM Volume 40 ?L
TABLE-US-00006 TABLE 6 Reaction conditions for reaction A2. Enzymes Concentration WCAG 0.8 ?g/?L GMD 1.4 ?g/?L GLK 0.129 ?g/?L PPK3 0.07 ?g/?L G6PDH 0.28 ?g/?L Substrates GDP-Man 4 mM NADPH 0.5 mM Glucose 10 mM ATP 1 mM PolyP.sub.25 2 mM Buffer and co-factor Tris-HCl (pH = 8) 100 mM MgCl.sub.2 10 mM Volume 50 ?L
TABLE-US-00007 TABLE 7 Reaction conditions of reaction A3. Enzymes Concentrations WCAG 0.3 ?g/?L GMD 0.52 ?g/?L GLK 0.09 ?g/?L PPK3 0.27 ?g/?L GLDH 2.99 ?g/?L ManB/C 0.046 ?g/?L PPA 0.047 ?g/?L Substrates Man 20 mM GTP 20 mM ATP 2 mM PolyP.sub.25 5 mM L-glutamate 50 mM NADPH 1 mM Buffer and co-factor Tris-HCl (pH = 9) 150 mM MgCl.sub.2 50 mM Volume 200 ?L
Example 7: Synthesis of GDP-Fucose from
[1314] A one-pot enzymatic reaction was conducted to validate GDP-fucose synthesis from mannose through the cascade shown in
TABLE-US-00008 TABLE 8 Reaction conditions as used in example 7. Enzymes Concentrations GSK 0.128 ?g/?L GMK 0.034 ?g/?L PPK3 0.2 ?g/?L GLK 0.11 ?g/?L MANB/C 0.071 ?g/?L WCAG 0.24 ?g/?L GMD 0.4 ?g/?L GLDH 3.45 ?g/?L PPA 0.04 ?g/?L Substrates Man 11.5 mM Guanosine (in DMSO) 11.5 mM ATP 2.9 mM PolyP.sub.25 5.17 mM L-glutamate 86 mM NADPH 2.8 mM Buffer and co-factor Tris-HCl (pH = 8) 115 mM MgCl.sub.2 29 mM Volume 175 ?L
Example 8: Synthesis of GDP-Fucose from
[1315] A one-pot enzymatic reaction was conducted to validate GDP-fucose synthesis from mannose through the cascade shown in
TABLE-US-00009 TABLE 9 Reaction conditions for example 8. Enzymes Concentration GSK 0.12 ?g/?L GMK 0.03 ?g/?L PPK3 0.19 ?g/?L NAHK 0.14 ?g/?L MANB/C 0.06 ?g/?L WCAG 0.22 ?g/?L GMD 0.38 ?g/?L GLDH 3.26 ?g/?L PPA 0.03 ?g/?L Substrates Man 10.9 mM Guanosine (in DMSO) 10.9 mM ATP 2.75 mM PolyP.sub.25 4.9 mM L-glutamate 81 mM NADPH 2.6 mM Buffer and co-factor Tris-HCl (pH = 8) 108 mM MgCl.sub.2 27 mM Volume 185 ?L
Example 9: Synthesis of 3-fucosyllactose
[1316] The cascades for GDP-fucose production can be coupled to fucosyltransferases to fucosylate molecules or biomolecules, e.g. human milk oligosaccharides and therapeutic proteins. The coupling is performed in one-pot reactions (see
##STR00009##
TABLE-US-00010 TABLE 10 Reaction conditions for reaction D1. Enzymes Concentration GSK 0.128 ?g/?L GMK 0.034 ?g/?L PPK3 0.2 ?g/?L GLK 0.11 ?g/?L MANB/C 0.071 ?g/?L WCAG 0.24 ?g/?L GMD 0.4 ?g/?L GLDH 3.45 ?g/?L PPA 0.04 ?g/?L 3/4FT 0.07 ?g/?L Substrates Man 8.7 mM Guanosine (in DMSO) 2.9 mM ATP 2.9 mM PolyP.sub.25 5.2 mM L-glutamate 29 mM NADPH 1.45 mM Lactose 11.6 mM Buffer and co-factor Tris-HCl (pH = 8) 116 mM MgCl.sub.2 43 mM Volume 172 ?L
TABLE-US-00011 TABLE 11 Reaction conditions for reaction D2. Enzymes Concentration GSK 0.16 ?g/?L GMK 0.042 ?g/?L PPK3 0.25 ?g/?L FKP 0.42 ?g/?L PPA 0.05 ?g/?L 3/4FT 0.07 ?g/?L Substrates Fucose 14.1 mM Guanosine (in DMSO) 3.5 mM ATP 3.6 mM PolyP.sub.25 6.3 mM Lactose 14.1 mM Buffer and co-factor Tris-HCl (pH = 8) 141 mM MgCl.sub.2 35 mM Volume 141 ?L
Example 10: Production of
[1317] The cascade described in examples 7 and 8 can be used to produce
[1318] A sequence listing is attached to this application comprising the sequences of the following table:
TABLE-US-00012 SEQ ID description 1 Glucokinase 2 Phosphomannomutase 3 N-acetylhexosamine-1-kinase 4 Mannose-1-phosphate guanylyltransferase 5 GDP-mannose 4,6-dehydratase 6 GDP-L-fucose synthase 7 L-fucokinase 8 Guanosine kinase 9 2-domain polyphosphate kinase 2 10 inorganic pyrophosphatase 11 Guanylate kinase 12 Glutamate dehydrogenase 1 (GLDH) 13 Glucose-6-phosphate 1-dehydrogenase (G6PDH) 14 phosphotransferase 3 (PPK3) 15 Glucose/galactose 1-dehydrogenase (GDH) 16 alpha-1,3/4-fucosyltransferase (3/4FT)